Literature DB >> 10966116

Ionic and signal transduction alterations in Alzheimer's disease: relevance of studies on peripheral cells.

R Etcheberrigaray1, S Bhagavan.   

Abstract

Several lines of evidence indicate that Alzheimer's disease (AD) has systemic expression. Systemic changes are manifested as alterations in a number of molecular and cellular processes. Although, these alterations appear to have little or no consequence in peripheral systems, their parallel expression in the central nervous system (CNS) could account for the principal clinical manifestations of the disease. Recent research seems to indicate that alterations in ion channels, calcium homeostasis, and protein kinase C (PKC) can be linked and thereby constitute a model of pathophysiological relevance. Considering the difficulties of studying dynamic pathophysiological processes in the disease-ridden postmortem AD brain, peripheral tissues such as fibroblasts provide a suitable model to study molecular and cellular aspects of the disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10966116     DOI: 10.1007/BF02742436

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  122 in total

1.  Modeling, chemistry, and biology of the benzolactam analogues of indolactam V (ILV). 2. Identification of the binding site of the benzolactams in the CRD2 activator-binding domain of PKCdelta and discovery of an ILV analogue of improved isozyme selectivity.

Authors:  A P Kozikowski; S Wang; D Ma; J Yao; S Ahmad; R I Glazer; K Bogi; P Acs; S Modarres; N E Lewin; P M Blumberg
Journal:  J Med Chem       Date:  1997-04-25       Impact factor: 7.446

2.  Sequential modification of membrane currents with classical conditioning.

Authors:  C Collin; H Ikeno; J F Harrigan; I Lederhendler; D L Alkon
Journal:  Biophys J       Date:  1988-11       Impact factor: 4.033

3.  Amyloid beta protein potentiates Ca2+ influx through L-type voltage-sensitive Ca2+ channels: a possible involvement of free radicals.

Authors:  K Ueda; S Shinohara; T Yagami; K Asakura; K Kawasaki
Journal:  J Neurochem       Date:  1997-01       Impact factor: 5.372

4.  Increased spectrin proteolysis in fibroblasts from aged and Alzheimer donors.

Authors:  C Peterson; P Vanderklish; P Seubert; C Cotman; G Lynch
Journal:  Neurosci Lett       Date:  1991-01-02       Impact factor: 3.046

5.  DNA repair deficiency for alkylation damage in cells from Alzheimer's disease patients.

Authors:  W G Bradley; R J Polinsky; W W Pendlebury; S K Jones; L E Nee; J D Bartlett; J N Hartshorn; R Tandan; L Sweet; G K Magin
Journal:  Prog Clin Biol Res       Date:  1989

6.  Cytosolic free [Ca2+] in mononuclear blood cells from demented patients and healthy controls.

Authors:  B Bondy; U Klages; F Müller-Spahn; C Hock
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

7.  Excessive production of amyloid beta-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation.

Authors:  M Citron; C Vigo-Pelfrey; D B Teplow; C Miller; D Schenk; J Johnston; B Winblad; N Venizelos; L Lannfelt; D J Selkoe
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

Review 8.  Changes in protein kinases in brain aging and Alzheimer's disease. Implications for drug therapy.

Authors:  L W Jin; T Saitoh
Journal:  Drugs Aging       Date:  1995-02       Impact factor: 3.923

9.  Differential alterations of ion channel binding sites in temporal and occipital regions of the cerebral cortex in Alzheimer's disease.

Authors:  M Ikeda; D Dewar; J McCulloch
Journal:  Brain Res       Date:  1993-12-10       Impact factor: 3.252

10.  Ca2+ channel blockers attenuate beta-amyloid peptide toxicity to cortical neurons in culture.

Authors:  J H Weiss; C J Pike; C W Cotman
Journal:  J Neurochem       Date:  1994-01       Impact factor: 5.372

View more
  5 in total

1.  CRISPR Transcriptional Activation Analysis Unmasks an Occult γ-Secretase Processivity Defect in Familial Alzheimer's Disease Skin Fibroblasts.

Authors:  Keiichi Inoue; Luis M A Oliveira; Asa Abeliovich
Journal:  Cell Rep       Date:  2017-11-14       Impact factor: 9.423

2.  The effect of citalopram on gene expression profile of Alzheimer lymphocytes.

Authors:  András Palotás; László G Puskás; Klára Kitajka; Miklós Palotás; József Molnár; Magdolna Pákáski; Zoltán Janka; Botond Penke; János Kálmán
Journal:  Neurochem Res       Date:  2004-08       Impact factor: 3.996

3.  Therapeutic effects of PKC activators in Alzheimer's disease transgenic mice.

Authors:  René Etcheberrigaray; Mathew Tan; Ilse Dewachter; Cuno Kuipéri; Ingrid Van der Auwera; Stefaan Wera; Lixin Qiao; Barry Bank; Thomas J Nelson; Alan P Kozikowski; Fred Van Leuven; Daniel L Alkon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-19       Impact factor: 11.205

4.  Potential cognitive enhancing and disease modification effects of SSRIs for Alzheimer's disease.

Authors:  Tiffany W Chow; Bruce G Pollock; Norton W Milgram
Journal:  Neuropsychiatr Dis Treat       Date:  2007       Impact factor: 2.570

5.  The new KV3.4 inhibitor BDS-I[1-8] as a potential pharmacological opportunity in Alzheimer's disease therapy.

Authors:  Ilaria Piccialli; Roselia Ciccone; Anna Pannaccione
Journal:  Neural Regen Res       Date:  2020-07       Impact factor: 5.135

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.